Trials / Withdrawn
WithdrawnNCT01658852
Effects and Safety of Metronidazole in Patients With Gastrectomy
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The Catholic University of Korea · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Recent study showed that SIBO is common among postgastrectomy patients and It appears to be associated with postprandial intestinal symptoms and might aggravate late hypoglycemia. SIBO could be a new therapeutic target for managing intestinal symptoms in postgastrectomy patients.The purpose of this study is to determine whether antiboitic (metronidazole) is effective in patients with postgasrectomy syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | metronidazole | |
| DRUG | Placebo |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-08-07
- Last updated
- 2020-09-21
Source: ClinicalTrials.gov record NCT01658852. Inclusion in this directory is not an endorsement.